Showing results (11-20 of 541) with videos related to
Sort By:
Pageof 55
Alzheimer Disease and Associated Disorders|February 24, 2001
RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?J J Sramek, N R CutlerProgress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug developmentN R Cutler, J J SramekAlzheimer Disease and Associated Disorders|January 1, 1995
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study"N R Cutler, J J SramekExperimental Aging Research|January 1, 1983
Assessing the noradrenergic system in normal aging: a review of methodologyN R Cutler, J E HodesJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)|December 9, 2000
Women's health care during the perimenopauseE J Frackiewicz, N R CutlerAlzheimer Disease and Associated Disorders|July 3, 1998
Guidelines for conducting bridging studies in Alzheimer diseaseN R Cutler, J J SramekEuropean Journal of Clinical Pharmacology|January 1, 1995
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging studyN R Cutler, J J SramekThe Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R CutlerExpert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R CutlerNeurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
The bridging concept: optimizing dose for phase II/III in Alzheimer's diseaseN R Cutler, J J Sramek, J R KilbornPageof 55